Weidong Jia

Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study

Zhenggang Ren, Jianming Xu, Yuxian Bai et al. · The Lancet Oncology · 2021 · 1.1K citations

Medicine, Oncology, Pharmacology +13

Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)

Jian Zhou, Hui‐Chuan Sun, Zheng Wang et al. · Liver Cancer · 2020 · 833 citations · Full text

Medicine, Oncology, Gastrointestinal Oncology +13

Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)

Jian Zhou, Hui‐Chuan Sun, Zheng Wang et al. · Liver Cancer · 2023 · 452 citations · Full text

Medicine, Oncology, Cancer Control +12

ENO1 suppresses cancer cell ferroptosis by degrading the mRNA of iron regulatory protein 1

Tong Zhang, Linchong Sun, Yijie Hao et al. · Nature Cancer · 2021 · 203 citations

Medicine, Molecular Biology, Oncology +8

Hepatocellular carcinoma redirects to ketolysis for progression under nutrition deprivation stress

De Huang, Tingting Li, Lin Wang et al. · Cell Research · 2016 · 168 citations · Full text

Medicine, Nutritional Sciences, Oncology +14